NEWS RELEASE For Information:
FOR IMMEDIATE RELEASE Cari Reisinger
Drug Industry Critics Examine Influence of Marketing Tactics in Hard-hitting Documentary
LOS ANGELES, CA
– Medical experts and pharmaceutical industry critics expose how drug company
marketing tactics affect today’s healthcare system in the timely documentary, Money Talks: Profits Before
Patient Safety. Featuring interviews with investigative journalists and
medical professionals from Harvard,
Money Talks: Profits Before Patient Safety is filmmaker Kathleen Slattery-Moschkau’s second film about issues involving the pharmaceutical industry. Her debut feature, Side Effects, was a fictional treatment of her decade working as a sales rep for two of the nation’s top drug companies. Because of the questions posed by enthusiastic Side Effects audiences, Slattery-Moschkau felt compelled to take a more comprehensive, academic approach to the topic of pharmaceutical marketing tactics for her second film.
“Side Effects generated such an outstanding dialogue on the issues of drug promotion and ethics that we felt compelled to go to the experts,” said Slattery-Moschkau. “Money Talks is straight-shooting information every consumer should have.”
In Money Talks, Alex Sugerman-Brozan, Director of Prescription Access Litigation, shares shocking statistics about the pharmaceutical industry’s formidable marketing force. He cites that there are over 80,000 pharmaceutical sales reps employed in the
Harvard's Dr. John Abramson, author of Overdo$ed America, exposes how once-trusted entities like the Food and Drug Administration and The New England Journal of Medicine are no longer sources of unbiased information on prescription drugs due to their
financial ties to the pharmaceutical industry.
interviewees include Dr. Bob Goodman of
For more information on the issues raised in Money Talks, visit www.moneytalksthemovie.com. To arrange an interview with filmmaker Kathleen Slattery-Moschkau, contact Cari Reisinger of Hummingbird Pictures at (209) 736-6769 email@example.com.